Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator-initiated, Randomized, Double-blind, Placebo Controlled Study of Apremilast to Demonstrate Efficacy in Subjects With Nummular Eczema

NCT03160248 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT03160248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03160248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator-initiated, Randomized, Double-blind, Placebo Controlled Study of Apremilast to Demonstrate Efficacy in Subjects With Nummular Eczema
Lead sponsor
Technical University of Munich
Phase
Phase 2
Overall status
Completed
Start date
July 5, 2017
Completion date
September 15, 2021
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis eczema, eczema, nummular dermatitis, nummular eczema